White & Case advises Hayfin Capital Management on €550 million Juvisé Pharmaceuticals refinancing

Global law firm White & Case LLP has advised Hayfin Capital Management as sole noteholder on a €550 million unitranche financing for leading pharmaceutical company Juvisé Pharmaceuticals.

The transaction includes the refinancing of €400 million existing debt and a new €150 million capital expenditure line dedicated to future acquisitions.

Hayfin Capital Management is a leading European alternative asset management platform.

The White & Case team in Paris which advised on the transaction was led by partner Samir Berlat and included associates Martin Poirier and Imane Lazraq.

Press contact
For more information please speak to your local media contact.